Key #1 For Successful ePRO Selection In Your Ophthalmology Clinical Trial: Ensure The ePRO Answers The Intended Clinical Endpoint

PROs have become a vital part of modern ophthalmology with an increasing focus on PROs within high-quality ophthalmic trials. International organizations are now significant contributors to the development, access, and guidance for the best use of PROs.

Some of the benefits of a PRO or ePRO are that they can be used to evaluate a primary endpoint, a secondary endpoint, and an exploratory endpoint. Watch the available video to hear about the importance of carefully selecting the measure that will answer the intended endpoint, whether it be primary, secondary, or exploratory in ophthalmic trials while also factoring in the patients’ capabilities.

For more information on Clinical Technologies, visit the Clinical Leader page.